New partnership addresses key challenges for regulating digital mental health technologies

FHS
May 11, 2024
12:34 pm

An MHRA and NICE partnership, funded by Wellcome, is addressing key challenges for regulating and evaluating digital mental health technologies (DMHTs) with input from patients, the public and mental health professionals.

ChatGPT could be an effective tool to help reduce vaccine hesitancy

New research being presented at this year’s ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) suggests that the free-to-use, widely accessible ChatGPT could

April 11, 2024

ESC 2024: GLP-1RAs lower CV risk in meta-analysis of 32,883

Results have been presented at the European Society of Cardiology (ESC) Congress 2024 of a meta-analysis that studied the cardiovascular outcomes of glucagon-like peptide-1 receptor

September 2, 2024

STADA and Alvotech’s win first EU-approval for Stelara biosimilar – Pharmaceutical Technology

Share this article Alvotech and STADA received an EU approval for Uzpruvo. Credit: Waldemarus via Shutterstock STADA and Alvotech received a marketing authorisation from the

January 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.